<DOC>
	<DOCNO>NCT00938678</DOCNO>
	<brief_summary>This study compare pharmacokinetics , pharmacodynamics safety Pegfilgrastim Hospira NeulastaÂ® follow single dose 6 mg product administer subcutaneously Treatment Periods 1 2 , respectively , healthy volunteer .</brief_summary>
	<brief_title>Pharmacokinetic/Pharmacodynamic ( PK/PD ) Study Evaluating Pegfilgrastim Hospira Compared Neulasta ( Amgen ) Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject , 1855 year inclusive . Written informed consent give Willing able comply requirement protocol available plan duration study . Body Mass Index ( BMI ) 19 30 kg/m2 inclusive weight &lt; 50 kg &gt; 100 kg . Female subject use effective method contraception , surgically sterile . Nonsmokers exsmokers smoke within previous 12 month . Hypersensitivity Investigational medicinal product ( IMP ) constituent and/or hypersensitivity E. Coli derive protein , and/or previous exposure IMP . History presence clinically significant finding , opinion Investigator , would preclude inclusion study . History presence clinically significant gastrointestinal pathology symptom , liver kidney disease , condition might interfere absorption , distribution , metabolism excretion drug . Any clinically significant laboratory finding , include ANC , platelet haemoglobin result outside reference range local laboratory . Abnormal vital sign abnormal 12lead electrocardiogram ( ECG ) result , judge Investigator clinically significant . Females , pregnant lactating , plan become pregnant time subject study . Subjects history pulmonary infiltrate pneumonia previous 6 month date screen visit . Hereditary fructose intolerance . Participation clinical trial use investigational product device , within previous 12 week date screen visit . Positive result human immunodeficiency virus ( HIV ) and/or hepatitis B C test . Evidence , treatment , drug alcohol abuse within one year date screen visit . Blood donation &gt; =500 mL previous 12 week date screen visit . Use prescription medication ( exclude hormonal contraceptive ) within 14 day prior date screen visit . Receipt overthecounter medicine yet clear body ( five halflives must pass medicine consider clear body ) . Vitamins , mineral nutritional supplement may take discretion Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>